Table 3.
Treatment Failure for CA-UTI Patients Based on Antibiotic Selection and Duration
| Unadjusted | Adjusted* | |||
|---|---|---|---|---|
| Antibiotic selection | RR (95% CI) | P-value | RR (95% CI) | P-value |
| Amoxicillin-clavulanate | 1.09 (0.99, 1.21) | 0.08 | 1.08 (0.98, 1.19) | 0.12 |
| Amoxicillin | 0.93 (0.83, 1.04) | 0.21 | 0.94 (0.84, 1.05) | 0.27 |
| Cefadroxil, Cephalexin | 1.09 (1.00, 1.19) | 0.06 | 1.09 (1.00, 1.19) | 0.05 |
| Nitrofurantoin | 0.99 (0.92, 1.07) | 0.84 | 1.02 (0.94, 1.10) | 0.65 |
| Trimethoprim-sulfamethoxazole | referent | . | referent | . |
| Ciprofloxacin, Levofloxacin | 0.91 (0.84, 0.98) | 0.01 | 0.91 (0.85, 0.98) | 0.02 |
| Fosfomycin | 1.05 (0.92, 1.19) | 0.46 | 1.04 (0.92, 1.18) | 0.51 |
*
Adjusted for age, sex, Charlson comorbidity score, acute care, and long-term care days in the past 12 months.